Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Bromhidrosis

  • Author: Wingfield Rehmus, MD, MPH; Chief Editor: William D James, MD  more...
 
Updated: Jun 21, 2016
 

Background

Bromhidrosis, also known as osmidrosis, bromidrosis or body odor, is a common phenomenon in postpubertal individuals. In rare cases, bromhidrosis may become pathologic if it is particularly overpowering or if the bromhidrosis significantly interferes with the lives of the affected individuals. Bromhidrosis is a chronic condition in which excessive odor, usually an unpleasant one, emanates from the skin. Bromhidrosis is determined largely by apocrine gland secretion and can substantially impair a person's quality of life.

Next

Pathophysiology

Types of glands and their functions

Human secretory glands are primarily divided into two types: apocrine and eccrine.

Eccrine glands are distributed over the entire skin surface, where they are involved in thermoregulation by means of sweat production.[1]

In contrast, apocrine glands have a limited distribution involving the axilla, genital skin, and breasts. Apocrine elements are also found in the periorbital and periauricular areas. Apocrine glands have no thermoregulatory role but are responsible for characteristic pheromonal odors. They secrete a small amount of oily fluid, which is odorless upon reaching the skin surface. The characteristic odor is due to bacterial decomposition of the oily fluid.[2, 3] Studies have shown that in comparison to controls, individuals with bromhidrosis display more numerous and larger apocrine glands.

Lastly, apoeccrine glands are sweat glands that become apparent between the ages of 8 and 14 years. They are functionally and pharmacologically distinct from apocrine glands and contribute heavily to overall axillary sweating. They develop during puberty from eccrinelike precursor glands.

Histological findings suggest that eccrine glands are dominant in the dermis.  Apocrine glands are located in the lower part of the reticular dermis and the subcutaneous tissue.  They are much larger than eccrine glands.

Control of apocrine glands

Current evidence suggests that the human apocrine gland appears to be under sympathetic nervous control with the peripheral mechanisms regulated by catecholamines. The presence of purinergic receptors within the gland also indicates the use of a secondary sudomotor pathway with nucleotide involvement in the secretory glands.[4]

Apocrine bromhidrosis

Apocrine bromhidrosis is the most prevalent form of bromhidrosis and should be differentiated from the less common eccrine bromhidrosis. Several factors contribute to the pathogenesis of apocrine bromhidrosis. Bacterial decomposition of apocrine secretion yields ammonia and short-chain fatty acids, with their characteristic strong odors. The most abundant of these acids is (E)-3-methyl-2-hexanoic acid (E-3M2H), which is brought to the skin surface bound by 2 apocrine secretion odor-binding proteins, ASOB1 and ASOB2. ASOB2 has been identified as apolipoprotein D (apoD), a known member of the lipocalin family of carrier proteins.[5, 6, 7]

Axillary bacterial florae have been shown to produce the distinctive axillary odor by transforming nonodoriferous precursors in sweat to more odoriferous volatile acids. The most common of these are E-3M2H and (RS)-3-hydroxy-3-methlyhexanoic acid (HMHA), which are released through the action of a specific zinc-dependent N -alpha-acyl-glutamine aminoacylase (N-AGA) from Corynebacterium species. This aminoacylase has been demonstrated to also release other odoriferous acids from glutamine conjugates in sweat, which may be the basis of individual body odor.[8]

Eccrine bromhidrosis

In certain circumstances, eccrine secretion, which is typically odorless, assumes an offensive aroma and causes eccrine bromhidrosis. When eccrine sweat softens keratin, bacterial degradation of the keratin yields a foul smell. Ingestion of some foods, including garlic, onion, curry, alcohol, certain drugs (eg, penicillin, bromides), and toxins may also cause eccrine bromhidrosis. Lastly, eccrine bromhidrosis may result from underlying metabolic or endogenous causes.

The role of excessive eccrine secretion, or hyperhidrosis, in the pathogenesis of bromhidrosis is unclear. Hyperhidrosis may promote the spread of apocrine sweat and contribute further to bromhidrosis by creating a moist environment, one ripe for bacterial overgrowth.[9, 10] Conversely, eccrine hyperhidrosis may cause a decrease in odor because the eccrine sweat flushes away the more odoriferous apocrine sweat.

Genetic involvement

Most patients have family members who also have bromhidrosis. An autosomal dominant inheritance pattern has been proposed in one study. Recent studies have found a strong relationship between bromhidrosis and wet ear wax associated with the single nucleotide polymorphism (SNP) rs 17822931 of the ABCC11 gene.[11, 12]

Previous
Next

Epidemiology

Frequency

United States

The incidence of bromhidrosis is unclear.  The diagnosis is generally considered rare, but is likely underreported.

International

The diagnosis of bromhidrosis is more common in many Asian countries, where even minimal body odor is associated with personal distress, and can be diagnosed as bromhidrosis, more so than in other regions of the world. Although the incidence of bromhidrosis is not reported, the social stigma of body odor leads more patients to seek treatment in these countries than in other countries.

Race

Apocrine bromhidrosis is believed to be more common in patients in dark-skinned ethnic groups than in others.

In Asian patients, apocrine bromhidrosis may be associated with a positive family history.

Eccrine bromhidrosis occurs in persons of all races.

Sex

Bromhidrosis exhibits a male predominance, which may be a reflection of greater apocrine gland activity in men compared with women.

Age

Axillary bromhidrosis depends on apocrine function and therefore manifests exclusively after puberty. It occurs only rarely in the elderly population.

In contrast, eccrine bromhidrosis is more common than apocrine bromhidrosis during childhood, but it may occur at any age.

Previous
Next

Prognosis

No morbid sequelae are known for bromhidrosis.

Previous
Next

Patient Education

Patients with bromhidrosis should be encouraged to maintain an appropriate level of hygiene with the use of antibacterial soaps and antiperspirants. Bromhidrosis patients also should be aware of the odor that may arise from dried sweat on clothes.

Previous
 
 
Contributor Information and Disclosures
Author

Wingfield Rehmus, MD, MPH Dermatologist, BC Children's Hospital, Vancouver, British Columbia

Wingfield Rehmus, MD, MPH is a member of the following medical societies: American Academy of Dermatology, Society for Pediatric Dermatology

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Abbvie; Valeant Canada<br/> Received honoraria from Valeant Canada for advisory board; Received honoraria from Pierre Fabre for advisory board; Received honoraria from Mustella for advisory board; Received honoraria from Abbvie for advisory board.

Specialty Editor Board

David F Butler, MD Section Chief of Dermatology, Central Texas Veterans Healthcare System; Professor of Dermatology, Texas A&M University College of Medicine; Founding Chair, Department of Dermatology, Scott and White Clinic

David F Butler, MD is a member of the following medical societies: American Medical Association, Alpha Omega Alpha, Association of Military Dermatologists, American Academy of Dermatology, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Phi Beta Kappa

Disclosure: Nothing to disclose.

Jeffrey J Miller, MD Associate Professor of Dermatology, Pennsylvania State University College of Medicine; Staff Dermatologist, Pennsylvania State Milton S Hershey Medical Center

Jeffrey J Miller, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Society for Investigative Dermatology, Association of Professors of Dermatology, North American Hair Research Society

Disclosure: Nothing to disclose.

Chief Editor

William D James, MD Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology, Society for Investigative Dermatology

Disclosure: Nothing to disclose.

Additional Contributors

Timothy McCalmont, MD Director, UCSF Dermatopathology Service, Professor of Clinical Pathology and Dermatology, Departments of Pathology and Dermatology, University of California at San Francisco; Editor-in-Chief, Journal of Cutaneous Pathology

Timothy McCalmont, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, American Society of Dermatopathology, California Medical Association, College of American Pathologists, United States and Canadian Academy of Pathology

Disclosure: Received consulting fee from Apsara for independent contractor.

Acknowledgements

Katherine Brown Stanford University School of Medicine

Katherine Brown, is a member of the following medical societies: American Medical Student Association/Foundation

Disclosure: Nothing to disclose.

Carol E Cheng, MD Attending Physician, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School

Disclosure: Nothing to disclose.

Nelly Rubeiz, MD Consulting Staff, Department of Dermatology, American University of Beirut Medical Center; Associate Professor, Department of Dermatology, American University of Beirut, Lebanon

Disclosure: Nothing to disclose.

Shereen S Timani, MD Staff Physician, Department of Dermatology, American University of Beirut, Lebanon

Disclosure: Nothing to disclose.

References
  1. He J, Wang T, Dong J. A close positive correlation between malodor and sweating as a marker for the treatment of axillary bromhidrosis with botulinum toxin A. J Dermatolog Treat. 2011 Jul 31. [Medline].

  2. Guillet G, Zampetti A, Aballain-Colloc ML. Correlation between bacterial population and axillary and plantar bromidrosis: study of 30 patients. Eur J Dermatol. 2000 Jan-Feb. 10(1):41-2. [Medline].

  3. Leyden JJ, McGinley KJ, Holzle E, Labows JN, Kligman AM. The microbiology of the human axilla and its relationship to axillary odor. J Invest Dermatol. 1981 Nov. 77(5):413-6. [Medline].

  4. Lindsay SL, Holmes S, Corbett AD, Harker M, Bovell DL. Innervation and receptor profiles of the human apocrine (epitrichial) sweat gland: routes for intervention in bromhidrosis. Br J Dermatol. 2008 Sep. 159(3):653-60. [Medline].

  5. Natsch A, Derrer S, Flachsmann F, Schmid J. A broad diversity of volatile carboxylic acids, released by a bacterial aminoacylase from axilla secretions, as candidate molecules for the determination of human-body odor type. Chem Biodivers. 2006 Jan. 3(1):1-20. [Medline].

  6. Spielman AI, Sunavala G, Harmony JA, et al. Identification and immunohistochemical localization of protein precursors to human axillary odors in apocrine glands and secretions. Arch Dermatol. 1998 Jul. 134(7):813-8. [Medline].

  7. Zeng C, Spielman AI, Vowels BR, Leyden JJ, Biemann K, Preti G. A human axillary odorant is carried by apolipoprotein D. Proc Natl Acad Sci U S A. 1996 Jun 25. 93(13):6626-30. [Medline]. [Full Text].

  8. Sato T, Sonoda T, Itami S, Takayasu S. Predominance of type I 5alpha-reductase in apocrine sweat glands of patients with excessive or abnormal odour derived from apocrine sweat (osmidrosis). Br J Dermatol. 1998 Nov. 139(5):806-10. [Medline].

  9. Mao GY, Yang SL, Zheng JH. Cause of axillary bromidrosis. Plast Reconstr Surg. 2009 Feb. 123(2):81e-82e. [Medline].

  10. Mao GY, Yang SL, Zheng JH. Etiology and management of axillary bromidrosis: a brief review. Int J Dermatol. 2008 Oct. 47(10):1063-8. [Medline].

  11. Nakano M, Miwa N, Hirano A, Yoshiura K, Niikawa N. A strong association of axillary osmidrosis with the wet earwax type determined by genotyping of the ABCC11 gene. BMC Genet. 2009 Aug 4. 10:42. [Medline]. [Full Text].

  12. Shang D, Zhang X, Sun M, Wei Y, Wen Y. Strong association of the SNP rs17822931 with wet earwax and bromhidrosis in a Chinese family. J Genet. 2013. 92(2):289-91. [Medline].

  13. Eun HC, Kim KH, Lee YS. Unusual body odour due to a nasal foreign body in a child. J Dermatol. 1984 Oct. 11(5):501-3. [Medline].

  14. Golding IM. An unusual cause of bromidrosis. Pediatrics. 1965 Nov. 36(5):791-2. [Medline].

  15. Katz HP, Katz JR, Bernstein M, Marcin J. Unusual presentation of nasal foreign bodies in children. JAMA. 1979 Apr 6. 241(14):1496. [Medline].

  16. Lucky AW. Acquired bromhidrosis in an 8-year-old boy secondary to a nasal foreign body. Arch Dermatol. 1991 Jan. 127(1):129. [Medline].

  17. Moriarty RA. Nasal foreign body presenting as an unusual odor. Am J Dis Child. 1978 Jan. 132(1):97-8. [Medline].

  18. Mancini M, Panasiti V, Devirgiliis V, Pietropaolo V, Fioriti D, Nicosia R, et al. Bromhidrosis induced by sphingomonas paucimobilis: a case report. Int J Immunopathol Pharmacol. 2009 Jul-Sep. 22(3):845-8. [Medline].

  19. Michaud T, Tack B. [Laser hair removal]. Ann Dermatol Venereol. 2009 Oct. 136 Suppl 6:S330-4. [Medline].

  20. Helou J, Haber R, Kechichian E, Tomb R. A case of generalized bromhidrosis following whole-body depilatory laser. J Cosmet Laser Ther. 2015. Vol 17(6):318-20.

  21. Helou J, Habre M, Soutou B, Maatouk I, Ibrahim T, Tomb R. Reversibility of hyperhidrosis post axillary depilatory laser. Lasers Med Sci. 2014 Mar. Vol 29(2):717-21. [Medline].

  22. Miranda-Sivelo A, Bajo-Del Pozo C, Fructuoso-Castellar A. Unnecessary surgical treatment in a case of olfactory reference syndrome. Gen Hosp Psychiatry. 2013 Nov-Dec. 35(6):683.e3-4. [Medline].

  23. Bang YH, Kim JH, Paik SW, Park SH, Jackson IT, Lebeda R. Histopathology of apocrine bromhidrosis. Plast Reconstr Surg. 1996 Aug. 98(2):288-92. [Medline].

  24. Kunachak S, Wongwaisayawan S, Leelaudomlipi P. Noninvasive treatment of bromidrosis by frequency-doubled Q-switched Nd:YAG laser. Aesthetic Plast Surg. 2000 May-Jun. 24(3):198-201. [Medline].

  25. Lee KG, Kim SA, Yi SM, Kim JH, Kim IH. Subdermal Coagulation Treatment of Axillary Bromhidrosis by 1,444 nm Nd:YAG Laser: A Comparison with Surgical Treatment. Ann Dermatol. 2014 Feb. 26(1):99-102. [Medline].

  26. Jung SK, Jang HW, Kim HJ, Lee SG, Lee KG, Kim SY. A Prospective, Long-Term Follow-Up Study of 1,444 nm Nd:YAG Laser: A New Modality for Treating Axillary Bromhidrosis. Ann Dermatol. 2014 Apr. 26(2):184-8. [Medline].

  27. Jung SK, Jang HW, KIm HJ et al. A Prospective, Long-Term Follow-Up Study of 1,444 nm Nd:YAG Laser: A New Modality for Treating Axillary Bromhidrosis. Ann Dermatolog. 2014 Apr. 26(2):184-8. [Full Text].

  28. Heckmann M, Teichmann B, Pause BM, Plewig G. Amelioration of body odor after intracutaneous axillary injection of botulinum toxin A. Arch Dermatol. 2003 Jan. 139(1):57-9. [Medline].

  29. Heckmann M, Kutt S, Dittmar S, Hamm H. Making scents: improvement of olfactory profile after botulinum toxin-A treatment in healthy individuals. Dermatol Surg. 2007 Jan. 33(1 Spec No.):S81-7. [Medline].

  30. Lee JB, Kim BS, Kim MB, Oh CK, Jang HS, Kwon KS. A case of foul genital odor treated with botulinum toxin A. Dermatol Surg. 2004 Sep. 30(9):1233-5. [Medline].

  31. He J, Wang T, Dong J. A close positive correlation between malodor and sweating as a marker for the treatment of axillary bromhidrosis with Botulinum toxin A. J Dermatolog Treat. 2012 Dec. 23(6):461-4. [Medline].

  32. He J, Wang T, Dong J. Excision of apocrine glands and axillary superficial fascia as a single entity for the treatment of axillary bromhidrosis. J Eur Acad Dermatol Venereol. 2011 Jun 21. [Medline].

  33. Zhao J, Li S, Nabi O, Hu L, Gao X, Luo F. Treatment of axillary bromhidrosis through a mini-incision with subdermal vascular preservation: a retrospective study in 396 patients. Int J Dermatol. 2016 May 21. [Medline].

  34. Li Z, Sun C, Zhang J, Qi Y, Hu J. Excision of apocrine glands with preservation of axillary superficial fascia for the treatment of axillary bromhidrosis. Dermatol Surg. 2015 May. 41(5):640-4. [Medline].

  35. Battal NM, Hata Y. A classic surgical method for the treatment of axillary osmidrosis. Plast Reconstr Surg. 1997 Aug. 100(2):550-1. [Medline].

  36. Born G. Surgical treatment of axillary osmidrosis. Plast Reconstr Surg. 1995 Dec. 96(7):1753. [Medline].

  37. Fan YM, Wu ZH, Li SF, Chen QX. Axillary osmidrosis treated by partial removal of the skin and subcutaneous tissue en bloc and apocrine gland subcision. Int J Dermatol. 2001 Nov. 40(11):714-6. [Medline].

  38. Grazer FM. A noninvasive surgical treatment of axillary hyperhidrosis. Clin Dermatol. 1992 Jul-Sep. 10(3):357-64. [Medline].

  39. Park DH, Kim TM, Han DG, Ahn KY. A comparative study of the surgical treatment of axillary osmidrosis by instrument, manual, and combined subcutaneous shaving procedures. Ann Plast Surg. 1998 Nov. 41(5):488-97. [Medline].

  40. Wang HJ, Cheng TY, Chen TM. Surgical management of axillary bromidrosis--a modified skoog procedure by an axillary bipedicle flap approach. Plast Reconstr Surg. 1996 Sep. 98(3):524-9. [Medline].

  41. Wu WH, Ma S, Lin JT, Tang YW, Fang RH, Yeh FL. Surgical treatment of axillary osmidrosis: an analysis of 343 cases. Plast Reconstr Surg. 1994 Aug. 94(2):288-94. [Medline].

  42. He J, Wang T, Dong J. Excision of apocrine glands and axillary superficial fascia as a single entity for the treatment of axillary bromhidrosis. J Eur Acad Dermatol Venereol. 2012 Jun. 26(6):704-9. [Medline].

  43. Wang R, Yang J, Sun J. A minimally invasive procedure for axillary osmidrosis: subcutaneous curettage combined with trimming through a small incision. Aesthetic Plast Surg. 2015 Feb. 39(1):106-13.

  44. Inaba M, Anthony J, Ezaki T, Mackinstry C. Regeneration of axillary hair and related phenomena after removal of deep dermal and subcutaneous tissue by a special "shaving" technique. J Dermatol Surg Oncol. 1978 Dec. 4(12):921-5. [Medline].

  45. Kim IH, Seo SL, Oh CH. Minimally invasive surgery for axillary osmidrosis: combined operation with CO2 laser and subcutaneous tissue remover. Dermatol Surg. 1999 Nov. 25(11):875-9. [Medline].

  46. Lillis PJ, Coleman WP 3rd. Liposuction for treatment of axillary hyperhidrosis. Dermatol Clin. 1990 Jul. 8(3):479-82. [Medline].

  47. Ou LF, Yan RS, Chen IC, Tang YW. Treatment of axillary bromhidrosis with superficial liposuction. Plast Reconstr Surg. 1998 Oct. 102(5):1479-85. [Medline].

  48. Tung TC. Endoscopic shaver with liposuction for treatment of axillary osmidrosis. Ann Plast Surg. 2001 Apr. 46(4):400-4. [Medline].

  49. Seo SH, Jang BS, Oh CK, Kwon KS, Kim MB. Tumescent superficial liposuction with curettage for treatment of axillary bromhidrosis. J Eur Acad Dermatol Venereol. 2008 Jan. 22(1):30-5. [Medline].

  50. Chung S, Yoo WM, Park YG, Shin KS, Park BY. Ultrasonic surgical aspiration with endoscopic confirmation for osmidrosis. Br J Plast Surg. 2000 Apr. 53(3):212-4. [Medline].

  51. Hong JP, Shin HW, Yoo SC, et al. Ultrasound-assisted lipoplasty treatment for axillary bromidrosis: clinical experience of 375 cases. Plast Reconstr Surg. 2004 Apr 1. 113(4):1264-9. [Medline].

  52. Park S. Very superficial ultrasound-assisted lipoplasty for the treatment of axillary osmidrosis. Aesthetic Plast Surg. 2000 Jul-Aug. 24(4):275-9. [Medline].

  53. Kao TH, Pan HC, Sun MH, Chang CS, Yang DY, Wang YC. Upper thoracic sympathectomy for axillary osmidrosis or bromidrosis. J Clin Neurosci. 2004 Sep. 11(7):719-22. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.